Xiaomi Banned From Importing and Selling Handsets in India

anuragingle

Disciple
happydance.gif
 
It's a frandly injunction.

contrary to popular perception, India is actually guilty of overprotecting IP on this count

The patents allegedly relate to AMR technology, 2G and 3G technologies. These appear to be the same set of technology patents under which Ericsson had earlier sued two Indian telecom companies, Micromax and Intex. Despite the Indian telcos mounting a serious challenge to the Ericsson patents in the IPAB and High Court, the court proceeded to grant the injunction. It also bears noting that while Ericsson has largely favourable orders against Micromax and Gionee, it has, as yet, not been successful in restraining Intex.

more here
 
May be few are thinking its a Well Deserved judgement .. Xiaomi For playing with 100's of potential buyers initially in the name of Flash sales.
 
Definitely looks like a targeted attack against specific players in the market. Do the others really have licensing arrangement? IMO, anything that is to be enforced as a standard should not have associated patents held by a entity that has control over who they want to license it to.

Anyway, Its amusing seeing this in a country which gives virtually no protection to foreign companies holding medical patents who formulae are allowed to be stolen and used by local pharma companies to make cheaper clones of their medicines. Apparently, the company owning the formula is still held liable if any side effects are caused by usage of the duplicate. Many pharma companies have apparently been not introducing and pulling out new medicines from the Indian market because of it.
 
http://www.mondaq.com/india/x/349008/Patent/Indias+Overview+On+Standard+Essential+Patent+SEPs

Since becoming fully functional in October of 2009, the CCI has brought two investigations involving SEPs, one in November 2013, and the other in January 2014, both against Ericsson based on allegations that it violated its FRAND commitments by imposing discriminatory and "excessive" royalty rates and using Non-Disclosure Agreements (NDAs). According to the CCI, "forcing a party to execute an NDA" and "imposing excessive and unfair royalty rates" constitutes "prima facie" abuse of dominance and violation of section 4 of the Indian Competition Act, as does "imposing a jurisdiction clause debarring complainants from getting disputes adjudicated in the country where both parties were in business."

In both matters, the CCI stated that "prima facie the relevant product market" is "'the provision of SEP(s) for 2G, 3G and 4G technologies in GSM standard compliant mobile communication devices,' in India, in which "prima facie it is apparent that Ericsson was dominant." The investigations allege that Ericsson "seems to be acting contrary to the FRAND terms by imposing royalties linked with cost of product of user for its patents." Thus, "for the use of GSM chip in a phone costing Rs 100, royalty would be Rs. 1.25 but if this GSM chip is used in a phone of Rs. 1000, royalty would be Rs. 12.5." According to the CCI, "charging of two different license fees per unit phone for use of the same technology prima facie is discriminatory and also reflects excessive pricing vis-à-vis high cost phones." Furthermore, contends the CCI, "transparency is the hallmark of fairness, and" alleging that, Ericsson's use of NDAs "is contrary to the spirit of applying FRAND terms fairly and uniformly to similarly placed players."

The second investigation further alleges that, although Ericsson publicly claims that it offers a broadly uniform rate to all similarly placed potential licensees, its refusal to share commercial terms and royalty payments on the grounds of NDAs is "strongly suggestive of the fact that different royalty rates/commercial terms were being offered to the potential licensees belong to the same category."
 
Back
Top